Prosecution Insights
Last updated: April 19, 2026

National Marine Biodiversity Institute Of Korea

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18298798 NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Final Rejection Apr 11, 2023
18042238 OCTOPUS-DERIVED PEPTIDE OCTOPROMYCIN HAVING ANTIBACTERIAL AND ANTI-BIOFILM ACTIVITY AGAINST ACINETOBACTER BAUMANNII REYNOLDS, FRED H 1658 Non-Final OA Feb 20, 2023
18010139 COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL DISEASES RELATED TO COPPER METABOLISM, COMPRISING MULTI-COPPER OXIDASE PEPTIDE WANG, CHANG YU 1675 Non-Final OA Dec 13, 2022
17781669 PHARMACEUTICAL COMPOSITION COMPRISING SMALL OCTOPUS-DERIVED PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASE HIBBERT, CATHERINE S 1658 Final Rejection Jun 01, 2022

Managing National Marine Biodiversity Institute Of Korea's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month